SCHEDULE 13D/AFiled Mar 2, 7:00 PM ET

Vir Biotechnology, Inc. SCHEDULE 13D/A

ARCH Venture Fund IX, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.